Harbour BioMed Raises $102.8M in Series C Financing to Accelerate Development of Its Innovative Portfolio of Next Generation Biologics
Amount Raised
$102 Million
Round Type
Series C
United StatesBiotechnologyTherapeuticsBiopharmaDescription
Harbour BioMed (HBM) today announced completion of its Series C financing of $102.8 Million to accelerate development of its growing portfolio of next generation biologics targeting cancer, immunologic diseases, and COVID-19. The financing was led by new investors, Hudson Bay Capital, followed by OrbiMed, Country Garden VC, GTJA Investment Group, Octagon Capital, and Sage Partners, with additional investment from existing investor Greater Bay Area Investment Fund. The round follows a $75 million Series B+ financing the Company completed in March 2020.
Who else raised in Therapeutics and Biopharma around the same time
Companies in the same sectors as Harbour BioMed that raised within 45 days of this round, from Fundz verified event records.
- Cartesian Therapeutics, Inc. raised $25M on August 18, 2020.
- GENOCEA BIOSCIENCES, INC. raised $76M on August 3, 2020.
- Entero Therapeutics raised $22M on July 31, 2020.
- MBX Biosciences, Inc. raised $26M on July 27, 2020.
- MBX Biosciences, Inc. raised $34M (Series A) on July 27, 2020.
- Fate Therapeutics raised $50M on July 6, 2020.
Who to call at Harbour BioMed, and when
A new round usually means Harbour BioMed is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Harbour BioMed raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Harbour BioMed, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Harbour BioMed. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Harbour BioMed raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Harbour BioMed raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.